NYSE
VGNT
Last Price
US $45.54
Valuation
Financial
Performance
Cash flow to debt coverage
Versigent PLC cash flow to debt ratio of 91.83% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Free cash flow growth
Versigent PLC's free cash flow has decreased 3.99% from $501.00M last year to $481.00M, signaling decreasing performance
Debt-to-equity ratio
Versigent PLC's debt to equity ratio is 28.51, which means that the company's assets are unhealthy financed, signaling financial risk.
Debt-to-equity trend
Versigent PLC's debt has increased relative to shareholder equity from 0.27 last year to 28.51 today, signaling weakened financials
Net debt to EBITDA
Versigent PLC has a net cash position, so leverage is healthy.
Interest coverage
Versigent PLC earns at least as much interest as it pays. Interest obligations are fully covered.
Profit margin growth
Versigent PLC's profit margin has increased (14.12%) in the last year from 4.91% to 5.60%, signaling increasing performance
Current ratio
Versigent PLC's short-term assets of $3.26B exceed its short-term liabilities of $2.18B
Return on assets
Versigent PLC's return on assets of 9.67% is higher than the 5.00% threshold, indicating efficient asset utilization
Return on equity
Versigent PLC's return on equity of 59.90%, is higher than 15.00%, indicating good performance
Earnings quality
Versigent PLC's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Earnings stability
Versigent PLC has insufficient public price history to evaluate earnings stability.
Positive free cash flow
Versigent PLC has positive free cash flow, indicating the company generates cash after capital expenditures
Free cash flow yield
Versigent PLC has a free cash flow yield of 15.40%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Earnings growth
Versigent PLC's yearly earnings has increased 29.41% since last year from $408.00M to $528.00M, signaling increasing performance
Revenue growth
Versigent PLC's yearly revenue has increased 6.13% since last year from $8.31B to $8.82B, signaling increasing performance
Return on invested capital
ROIC 23.10% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
3-year revenue CAGR
Versigent PLC's 3-year revenue CAGR of 3.23% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Versigent PLC has insufficient public price history to evaluate revenue consistency.
Return on equity consistency
Versigent PLC has insufficient public price history to evaluate ROE consistency.
Cash Flow Valuation (DCF)
Versigent PLC has insufficient data to evaluate this check.
Earnings yield (TTM)
Versigent PLC has an earnings yield of 16.59%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
EBITDA Valuation
Versigent PLC is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
Versigent PLC has an EV/EBITDA ratio of 3.41x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
PEG ratio (TTM/FY)
Versigent PLC has insufficient diluted EPS history to calculate the PEG ratio.
Price-to-book ratio (FY)
Versigent PLC has a price-to-book ratio of 11.00x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Price-to-sales ratio (TTM)
Versigent PLC has a price-to-sales ratio of 0.34x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
59.90%
Return on equity
ROIC: 23.10%
Valuation History
6.3X
Price to Earnings
EV/EBITDA: 4.9X
Cash flow
Profit margin
-
Fair Value
Market $45.54
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.